<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Liver - MASH]]></title><description><![CDATA[Obsidian digital garden]]></description><link>http://github.com/dylang/node-rss</link><image><url>site-lib/media/favicon.png</url><title>Liver - MASH</title><link></link></image><generator>Webpage HTML Export plugin for Obsidian</generator><lastBuildDate>Thu, 29 Jan 2026 13:25:51 GMT</lastBuildDate><atom:link href="site-lib/rss.xml" rel="self" type="application/rss+xml"/><pubDate>Thu, 29 Jan 2026 13:25:50 GMT</pubDate><ttl>60</ttl><dc:creator></dc:creator><item><title><![CDATA[Pre-Think]]></title><description><![CDATA[
The maximum duration for which <a data-href="PCLS" href="pcls.html" class="internal-link" target="_self" rel="noopener nofollow">PCLS</a> can maintain functional viability under <a data-href="in vitro culture" href="in-vitro-culture.html" class="internal-link" target="_self" rel="noopener nofollow">in vitro culture</a> conditions, (ideally up to two weeks).
<br>Standardization of mouse strain selection and <a data-href="hepatic lobe sampling" href="hepatic-lobe-sampling.html" class="internal-link" target="_self" rel="noopener nofollow">hepatic lobe sampling</a> to improve the reproducibility of PCLS preparation. <br>Identification of <a data-href="viability and activity markers" href="viability-and-activity-markers.html" class="internal-link" target="_self" rel="noopener nofollow">viability and activity markers</a> for PCLS beyond <a data-href="cleaved caspase 3" href=".html" class="internal-link" target="_self" rel="noopener nofollow">cleaved caspase 3</a>. <br>Exploration of <a data-href="methodologies" href="methodologies.html" class="internal-link" target="_self" rel="noopener nofollow">methodologies</a> other than <a data-href="IHC" href=".html" class="internal-link" target="_self" rel="noopener nofollow">IHC</a> and <a data-href="WB" href="wb.html" class="internal-link" target="_self" rel="noopener nofollow">WB</a> for assessing tissue viability and functional integrity. <br>Systematic benchmarking against the existing PCLS literature, including a consolidated summary of <a data-href="culture medium" href="culture-medium.html" class="internal-link" target="_self" rel="noopener nofollow">culture medium</a> composition and critical <a data-href="operational parameters" href=".html" class="internal-link" target="_self" rel="noopener nofollow">operational parameters</a>. <br>Establishment of a PCLS based experimental platform for <a data-href="MASH" href=".html" class="internal-link" target="_self" rel="noopener nofollow">MASH</a> research, including the construction of a dedicated in vitro experimental unit and the overall experimental setup.
]]></description><link>pre-think.html</link><guid isPermaLink="false">Pre-Think.md</guid><pubDate>Thu, 29 Jan 2026 09:47:34 GMT</pubDate></item><item><title><![CDATA[culture medium]]></title><description><![CDATA[<a data-tooltip-position="top" aria-label="https://doi.org/10.1101/2024.09.16.613213" rel="noopener nofollow" class="external-link is-unresolved" href="https://doi.org/10.1101/2024.09.16.613213" target="_self"># <em></em>&nbsp;mouse precision cut tumour slices for modelling hepatocellular carcinoma</a>Ex-vivo
Williams’ Medium E (Sigma-Aldrich) supplemented with 1% penicillin-streptomycin, 1% L-glutamine, 1% pyruvate, 1 x insulin transferrin-selenium X, 2% fetal bovine serum and 100 nM dexamethasone, at 37°C supplemented with 5% CO2.
duration: 3 days<br><a data-tooltip-position="top" aria-label="https://pubmed.ncbi.nlm.nih.gov/27717970/" rel="noopener nofollow" class="external-link is-unresolved" href="https://pubmed.ncbi.nlm.nih.gov/27717970/" target="_self"># Maintenance of drug metabolism and transport functions in human precision-cut liver slices during prolonged incubation for 5 days</a>
Slices were pre-incubated for 1 h at 37 °C in a 12-well plate filled with 1.3 ml of WME (Gibco, Life Technology) saturated with 80 % O2/5 % CO2 while gently shaking 90 times/min. Thereafter, they were transferred to another 12-well plate filled with 1.3 ml of three different media saturated with 80 %O2/5CO2: WME (with l-glutamine, Invitrogen, Paisly, Scotland) supplemented with 25 mM glucose and 50 mg/ml gentamycin (Invitrogen), RegeneMed® medium: WME supplemented with RegeneMed® additives (L3STA), antibiotics (L3MAB) and supplements (L3STS) in ratio 100:15.1:1:2.5 (RegeneMed®, San Diego, CA, USA) or Cellartis® Hepatocyte Maintenance Medium: WME supplemented with Cellartis® Hepatocyte Maintenance Medium Supplements (Cat. No. Y30051, Takara Bio Europe AB, Gothenburg, Sweden) and 50 mg/ml gentamycin. PCLS were incubated for 5 days with medium being refreshed daily.<br><a data-tooltip-position="top" aria-label="https://app.jove.com/v/60992/murine-precision-cut-liver-slices-as-an-ex-vivo-model-of-liver-biology" rel="noopener nofollow" class="external-link is-unresolved" href="https://app.jove.com/v/60992/murine-precision-cut-liver-slices-as-an-ex-vivo-model-of-liver-biology" target="_self">Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology</a>
Video
in cutting chamber: Krebs-Henseleit buffer with 2 g/L glucose
In a tissue culture laminar flow hood, pipette 1 mL of William's E medium containing 2.0 g/L glucose, 10% fetal bovine serum (FBS), 2 mM L-glutamine supplement, 100 U/mL penicillin, and 100 µg/mL streptomycin into 12 well tissue culture plates. NOTE: Other antibiotics and antifungal agents may also be added. Some studies have used additives in the tissue incubation medium (i.e., dexamethasone and insulin10), but these can interfere with cell signaling.
duration: 5 days<br><a data-tooltip-position="top" aria-label="https://pubmed.ncbi.nlm.nih.gov/36818276/" rel="noopener nofollow" class="external-link is-unresolved" href="https://pubmed.ncbi.nlm.nih.gov/36818276/" target="_self"># A Microfluidic Device for Long-Term Maintenance of Organotypic Liver Cultures</a>
Base: DMEM
Supplements: 1% (v/v) penicillin-streptomycin
10% FBS
0.5 U/mL Insulin
20 ng/mL EGF
7 ng/mL Glucagon
7.5 μg/mL Hydrocortisone <br><a data-tooltip-position="top" aria-label="https://pubmed.ncbi.nlm.nih.gov/30963615/" rel="noopener nofollow" class="external-link is-unresolved" href="https://pubmed.ncbi.nlm.nih.gov/30963615/" target="_self"># A Bioreactor Technology for Modeling Fibrosis in Human and Rodent Precision-Cut Liver Slices</a>
Williams Medium E
2% FBS
1× Insulin Transferrin-Selenium X
1% (v/v) penicillin-streptomycin
L-glutamine
100nM Dexamethasone
duration: 6 days<br><a data-tooltip-position="top" aria-label="https://pubmed.ncbi.nlm.nih.gov/35708773/" rel="noopener nofollow" class="external-link is-unresolved" href="https://pubmed.ncbi.nlm.nih.gov/35708773/" target="_self"># Mouse precision-cut liver slices as an ex vivo model to study drug-induced cholestasis</a>
pre-heated (37 °C) and oxygenated (80%) Williams Medium E (1X, glutaMAX-1), which had been supplemented with 25 mM D-glucose monohydrate and 50 μg/ ml Gentamicin (denoted as WME GG).<br><a data-tooltip-position="top" aria-label="https://app.jove.com/t/67202/optimized-simplified-technique-for-production-culture-precision-cut" rel="noopener nofollow" class="external-link is-unresolved" href="https://app.jove.com/t/67202/optimized-simplified-technique-for-production-culture-precision-cut" target="_self">Optimized and Simplified Technique for the Production and Culture of Precision-Cut Liver Slices</a> Video Leica VT1000 S
Add to the William's Medium E (WME), 2 mM L-glutamine supplement, 10% Fetal Bovine Serum (FBS), 100 U/mL penicillin, and 100 μg/ mL streptomycin, 10 μg/mL Gentamycin, 25 mM DGlucose solution and 15 mM HEPES solution.Fill the vibratome tank with ice-cold Krebs buffer.]]></description><link>culture-medium.html</link><guid isPermaLink="false">culture medium.md</guid><pubDate>Wed, 28 Jan 2026 17:48:47 GMT</pubDate></item><item><title><![CDATA[PCLS]]></title><description><![CDATA[<a data-href="Vibramote" href="vibramote.html" class="internal-link" target="_self" rel="noopener nofollow">Vibramote</a>: Leica VT1000 SMethods
Liver tissue was cored using a 8-mm Stiefel biopsy punch (Medisave, Weymouth, UK). Cores were transferred to a metal mould, submerged in 3% low geling temperature agarose (A9414; Sigma-Aldrich, Poole, UK), and placed on ice for 2-5 minutes. Agaroseembedded liver cores were superglued to the vibratome mounting stage, submersed in the media chamber containing 4°C Hank’s balanced salt solution+, and cut using a Leica VT1200S vibrating blade microtome (Leica Biosystems, Milton Keynes, UK) at a speed 0.3 mm/sec, amplitude 2 mm, and thickness (step size) of 250 μm (Fig. 1A). PCLSs were transferred onto 8-μm-pore Transwell inserts and cultured under static conditions in standard 12-well plates (Greiner Bio-One, Kremsmuenster, Austria) or in a modified tissue culture plate (BioR plate) and rocked on the bioreactor platform (patent PCT/GB2016/053310) at a flow rate of 18.136 μL/sec (Fig. 1B,C and Supporting Fig. S1A). For comparison, PCLS were cultured in Kirstall Quasivivo (qv500) units according to the manufacturer’s instructions (Supporting Fig. S1B). All PCLSs were cultured in Williams medium E (W4128; SigmaAldrich), supplemented with 1% penicillin/streptomycin and l-glutamine, 1× insulin transferrin-selenium X, and 2% fetal bovine serum (Thermo Fisher Scientific, Cramlington, UK), and 100 nM of dexamethasome (Cerilliant, Texas, USA) at 37°C, supplemented with 5% CO2. Media were changed daily.
]]></description><link>pcls.html</link><guid isPermaLink="false">PCLS.md</guid><pubDate>Wed, 28 Jan 2026 13:46:41 GMT</pubDate></item><item><title><![CDATA[methodologies]]></title><description><![CDATA[Viability and Cytotoxicity
<a data-href="IHC" href=".html" class="internal-link" target="_self" rel="noopener nofollow">IHC</a><br>
<a data-href="IF" href=".html" class="internal-link" target="_self" rel="noopener nofollow">IF</a><br>
<a data-href="WB" href="wb.html" class="internal-link" target="_self" rel="noopener nofollow">WB</a><br>
<a data-href="H&amp;E staining" href=".html" class="internal-link" target="_self" rel="noopener nofollow">H&amp;E staining</a> --&gt; Tissue morphology and integrity<br><a data-href="ATP assay" href=".html" class="internal-link" target="_self" rel="noopener nofollow">ATP assay</a><br>
<a data-href="LDH assay" href=".html" class="internal-link" target="_self" rel="noopener nofollow">LDH assay</a><br>
<a data-href="MTT assay" href=".html" class="internal-link" target="_self" rel="noopener nofollow">MTT assay</a><br>
<a data-href="qRT-PCR" href=".html" class="internal-link" target="_self" rel="noopener nofollow">qRT-PCR</a>MASH induce]]></description><link>methodologies.html</link><guid isPermaLink="false">methodologies.md</guid><pubDate>Fri, 23 Jan 2026 14:09:18 GMT</pubDate></item><item><title><![CDATA[WB]]></title><link>wb.html</link><guid isPermaLink="false">WB.md</guid><pubDate>Fri, 23 Jan 2026 09:35:42 GMT</pubDate></item><item><title><![CDATA[viability and activity markers]]></title><description><![CDATA[
Viability and Cytotoxicity <a data-href="ATP assay" href=".html" class="internal-link" target="_self" rel="noopener nofollow">ATP assay</a>
LDH (lactate dehydrogenase) leakage assay, indicative of necrosis
MTT- or protein content quantification
cleaved caspase 3 ]]></description><link>viability-and-activity-markers.html</link><guid isPermaLink="false">viability and activity markers.md</guid><pubDate>Fri, 23 Jan 2026 09:34:59 GMT</pubDate></item><item><title><![CDATA[in vitro culture]]></title><link>in-vitro-culture.html</link><guid isPermaLink="false">in vitro culture.md</guid><pubDate>Wed, 21 Jan 2026 09:06:10 GMT</pubDate></item><item><title><![CDATA[Vibramote]]></title><link>vibramote.html</link><guid isPermaLink="false">Vibramote.md</guid><pubDate>Tue, 20 Jan 2026 16:35:18 GMT</pubDate></item><item><title><![CDATA[hepatic lobe sampling]]></title><description><![CDATA[ <a data-href="murine liver" href="murine-liver.html" class="internal-link" target="_self" rel="noopener nofollow">murine liver</a><br>
<a data-tooltip-position="top" aria-label="https://www.ncbi.nlm.nih.gov/books/NBK591154/figure/chapter_08_fig08.04/" rel="noopener nofollow" class="external-link is-unresolved" href="https://www.ncbi.nlm.nih.gov/books/NBK591154/figure/chapter_08_fig08.04/" target="_self">murine liver anatomy</a>	<img alt="Pasted image 20260120140534.png" src="pasted-image-20260120140534.png" target="_self">
mouse strain: C57BL/6J
age: 8-12 weeks<br>
sex: should also be considered <a data-tooltip-position="top" aria-label="https://cz5waila03cyo0tux1owpyofgoryroob.aminer.cn/6A/D7/F6/6AD7F61F1E11DE639B07C601A10905BE.pdf" rel="noopener nofollow" class="external-link is-unresolved" href="https://cz5waila03cyo0tux1owpyofgoryroob.aminer.cn/6A/D7/F6/6AD7F61F1E11DE639B07C601A10905BE.pdf" target="_self">Cuño‑Gómiz et al., 2023</a> sampling part: left lateral lobe
much more smaller than human liver, pathological variability limited easy to operate, left lateral lob is superficial
better represetativeness: stable metabolic enzyme expression and hemodynamic characteristics cutting direction: parallel to lobule <br>
<a data-href="human liver" href=".html" class="internal-link" target="_self" rel="noopener nofollow">human liver</a><br>
<a data-tooltip-position="top" aria-label="https://www.britannica.com/science/liver" rel="noopener nofollow" class="external-link is-unresolved" href="https://www.britannica.com/science/liver" target="_self">human liver anatomy</a><img alt="Pasted image 20260120143710.png" src="pasted-image-20260120143710.png" target="_self">
sampling part: from both lobs
why?<br>
- Corrected fibrosis staging in 21% of cases&nbsp;(8 of 38 patients) when left lobe sampling was added to right lobe assessment. (<a data-tooltip-position="top" aria-label="https://pubmed.ncbi.nlm.nih.gov/30993598/" rel="noopener nofollow" class="external-link is-unresolved" href="https://pubmed.ncbi.nlm.nih.gov/30993598/" target="_self">S. Khurana et al., 2019</a>)
- Inflammatory infiltration may be unevenly distributed across different hepatic lobes. Fibrotic patterns can exhibit regional heterogeneity, and the degree of steatosis may vary significantly among different areas of the liver. 病人样本无法选择 ]]></description><link>hepatic-lobe-sampling.html</link><guid isPermaLink="false">hepatic lobe sampling.md</guid><pubDate>Tue, 20 Jan 2026 16:30:13 GMT</pubDate><enclosure url="." length="0" type="false"/><content:encoded>&lt;figure&gt;&lt;img src=&quot;.&quot;&gt;&lt;/figure&gt;</content:encoded></item><item><title><![CDATA[Pasted image 20260120143710]]></title><description><![CDATA[<img src="pasted-image-20260120143710.png" target="_self">]]></description><link>pasted-image-20260120143710.html</link><guid isPermaLink="false">Pasted image 20260120143710.png</guid><pubDate>Tue, 20 Jan 2026 13:37:10 GMT</pubDate><enclosure url="." length="0" type="false"/><content:encoded>&lt;figure&gt;&lt;img src=&quot;.&quot;&gt;&lt;/figure&gt;</content:encoded></item><item><title><![CDATA[Pasted image 20260120140534]]></title><description><![CDATA[<img src="pasted-image-20260120140534.png" target="_self">]]></description><link>pasted-image-20260120140534.html</link><guid isPermaLink="false">Pasted image 20260120140534.png</guid><pubDate>Tue, 20 Jan 2026 13:05:34 GMT</pubDate><enclosure url="." length="0" type="false"/><content:encoded>&lt;figure&gt;&lt;img src=&quot;.&quot;&gt;&lt;/figure&gt;</content:encoded></item><item><title><![CDATA[murine Liver]]></title><link>murine-liver.html</link><guid isPermaLink="false">murine Liver.md</guid><pubDate>Tue, 20 Jan 2026 12:56:35 GMT</pubDate></item></channel></rss>